More recently, de Oliveira et al.83 performed a systematic meta-analysis to assess the treatment efficacy and safety of monoclonal antibodies specifically targeting IL-4, IL-5, and IL-13 signals in treating EoE. Here, IL13 is linked to eosinophilic esophagitis.